DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Schoeffski P, Reichardt P, Blay JY et al.
A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors.
Ann Oncol 2010;
21: 1990-1998
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.